EcoDrugPlus

Ensembl ID : YJR145C
Description: -
125 Possible Orthologues:

Title

Ensembl ID : YJR155W
Description: -
800 Possible Orthologues:

Title

Ensembl ID : YJR159W
Description: -
155 Possible Orthologues:

Title

Ensembl ID : YKL006W
Description: -
94 Possible Orthologues:

Title

Ensembl ID : YKL019W
Description: -
64 Possible Orthologues:

Title

Ensembl ID : YKL055C
Description: -
435 Possible Orthologues:

Title

Ensembl ID : YKL094W
Description: -
113 Possible Orthologues:

Title

Ensembl ID : YKL145W
Description: -
84 Possible Orthologues:

Title

Ensembl ID : YKL161C
Description: -
771 Possible Orthologues:

Title

Ensembl ID : YKL166C
Description: -
229 Possible Orthologues:

Title

Ensembl ID : YKL171W
Description: -
333 Possible Orthologues:

Title

Ensembl ID : YKL180W
Description: -
128 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).